CION Ameerpet
Types & Staging · Reviewed by CION Oncologists · NABH Accredited
Endometrial vs Ovarian Cancer — How They Differ
These two are frequently spoken of together as “gynae cancers”, which obscures how different they are. The difference that matters most is timing. Endometrial cancer arises in the lining of the uterus and bleeds early, so most cases are found while still confined to the uterus. Ovarian cancer arises deep in the pelvis and produces vague symptoms — bloating, feeling full quickly, abdominal discomfort — that are easily attributed to something else, so most cases are found late. Almost every difference in how they are treated and how they turn out follows from that one fact. This page sets out the comparison, and corrects a common belief about screening.
- Endometrial bleeds early — which is why most are caught at stage I
- Ovarian is usually quiet until late — the symptoms are vague and ordinary
- Neither has effective screening — including CA-125 and ultrasound
- Both can occur in Lynch syndrome — which is why genetics matters in each
17+
Cancer Specialists
on Panel
on Panel
35+
Centres
Across India
Across India
15,000+
Patients
Treated
Treated
4.8★
Google Rating
(800+ reviews)
(800+ reviews)
The Two Compared
Neighbouring organs, genuinely different diseases.
| Endometrial cancer | Ovarian cancer | |
|---|---|---|
| Where it starts | The lining of the uterus. | The ovary or, for the commonest aggressive type, the fallopian tube. |
| Typical symptoms | Abnormal bleeding, above all after menopause. Unmistakable and early. See bleeding after menopause. | Persistent bloating, feeling full quickly, abdominal or pelvic discomfort, urinary frequency. Vague and easily attributed elsewhere. |
| Stage at diagnosis | Usually early, confined to the uterus. | Usually advanced, with spread within the abdomen. |
| How it is diagnosed | Ultrasound then a biopsy of the lining, often in one visit. See endometrial biopsy. | Imaging and CA-125 to assess a mass, with diagnosis usually confirmed at surgery or by biopsy of deposits. |
| Role of CA-125 | Limited. Not diagnostic, often normal even with cancer present. See the CA-125 test. | Established, in assessing an ovarian mass and monitoring known disease. Still not a screening test. |
| First treatment | Surgery for almost everyone, with treatment afterwards decided on the final pathology. | Surgery and chemotherapy, sometimes with chemotherapy given first to shrink disease before an operation. |
| Genetic links | Lynch syndrome. See Lynch syndrome. | BRCA1 and BRCA2 principally, and Lynch syndrome as well. |
Neither disease has an effective screening test for women at ordinary risk. This surprises people, particularly where a health package includes CA-125 and a pelvic ultrasound described as a check for gynaecological cancer. Large trials of ovarian screening have not shown a reduction in deaths, and nothing has been shown to work for endometrial cancer. Responding promptly to symptoms is what works.
Did You Know? The reason endometrial cancer generally has better outcomes than ovarian cancer is not that it is a gentler disease stage for stage. It is that it declares itself sooner. Bleeding after menopause is unmistakable and sends women to a doctor while the disease is still inside the uterus. Ovarian cancer, by contrast, produces bloating and abdominal discomfort that any woman might reasonably attribute to diet, to irritable bowel or to getting older — and by the time the pattern is undeniable, disease has often spread within the abdomen. This is why so much emphasis is placed on responding to postmenopausal bleeding: it is the early-warning system endometrial cancer has and ovarian cancer lacks. Sources: NCCN Clinical Practice Guidelines in Oncology — Uterine Neoplasms and Ovarian Cancer; ESGO–ESTRO–ESP guidelines for the management of patients with endometrial carcinoma; UK Collaborative Trial of Ovarian Cancer Screening.
12+ Centres in Hyderabad · Pick yours
CION cancer care is closer than you think.
We're never more than 30 minutes away. Same panel of specialists at every centre. Same tumour board reviews. Same NCCN protocols. Pick the closest one and call directly — or let us pick for you.
CION Ameerpet
CION Kukatpally
CION L.B. Nagar
CION Tolichowki
CION Masab Tank
CION Banjara Hills
CION Kompally
CION Balanagar
CION Siddipet
CION Sangareddy
Not sure which centre fits best? Tell us where you are — we'll suggest the closest one with the right specialists.
Help me pick the right centre
Beyond Hyderabad
35+ centres across Telangana & Andhra Pradesh
Travelling for treatment? We may have a centre right where you are.
Telangana
Andhra Pradesh
Don't see your city? Call 18002028726 — we'll find your nearest CION partner centre.
Where the Two Genuinely Overlap
Four situations where the distinction becomes less clean, and each is worth recognising.
- Both ovaries are removed in endometrial cancer surgery. Standard practice, both because the ovaries are a site of possible spread and because they produce the oestrogen that drove the tumour. It is why the operation causes menopause in a woman not already through it. See removing tubes and ovaries.
- Two cancers can occur at once. Synchronous endometrial and ovarian tumours are a recognised entity, occurring disproportionately in younger women. Where they are genuinely two independent primaries rather than one that has spread, the outlook is often considerably better — and the distinction is made on pathology, not on imaging.
- Lynch syndrome raises the risk of both. Which is one reason mismatch repair testing on an endometrial tumour matters beyond that tumour. See MMR and MSI testing.
- Endometrial cancer can spread to the ovary. Which is a different situation from having two cancers, and is distinguished by pathological and molecular assessment. It affects both stage and treatment, so it is worth asking which your report describes.
- Serous carcinoma occurs in both. Uterine serous carcinoma behaves in ways reminiscent of ovarian serous cancer, including its tendency to spread within the abdomen, which is why staging surgery for it includes omental assessment. See serous carcinoma.
Confused About Which Diagnosis You Have?
Bring your reports. We will go through what they say and what it means, in plain language.
Meet the Specialists
17+ senior cancer specialists. One panel for your case.
Trained at AIIMS, Tata Memorial, and leading international centres. Combined 150+ years of experience. Every complex case is reviewed by 3+ of them — together.
Medical Oncologist
Medical Oncologist
Dr. C. Raghavendra Reddy
MBBS(Gold Medal), DNB(General Medicine), DM(Medical Oncology)(Gold Medal)
Medical Oncologist
Dr. Bharati Devi Gorantla
MBBS, MD(General Medicine), DM(Medical Oncology)(Adyar,Chennai), ECMO, MRCP SCE(UK)
Medical Oncologist
Dr. Owais Mohammed
MBBS, MD (General Medicine), DrNB (Medical Oncology), ECMO, MRCP SCE (Medical Oncology) (UK)
Medical Oncologist
Medical Oncologist
Surgical Oncologist
Dr. Muralidhar Muddusetty
MBBS (AIIMS), MS (Surgery) (AIIMS), DNB (Surgical Oncology), MRCS (Edinburgh)
Surgical Oncologist
Surgical Oncologist
Surgical Oncologist
Dr. Vinay Mamidala
MBBS, MS(General Surgery), M.Ch(Surgical Oncology), FMAS, FARIS(Ongoing)
Surgical Oncologist
Radiation Oncologist
Radiation Oncologist
Radiation Oncologist
Hematologist
Interventional Radiologist
Dr. Mohammed Imran
Surgical Oncologist
Dr. Vajja Sandeep Kumar
MBBS, MS (General Surgery), DrNB (Surgical Oncology), FALS Oncology
Surgical Oncologist
Want a specific doctor for your case? Mention them when booking.
Book Free ConsultationBook an appointment with our specialist
Share your name and number — we'll call you back within 30 minutes to schedule your consultation.
Neither Is Screened For
A CA-125 and a pelvic scan in a health package is not a check for gynaecological cancer.
The Symptoms Worth Knowing for Each
Since neither is screened for, symptom awareness is what there is.
Any bleeding after menopause
The endometrial one, and the clearest signal in gynaecological oncology. Bleeding a year or more after your last period should always be assessed, however light and however brief. Around nine in ten women who report it do not have cancer, and it is investigated every time because it is how the disease is caught while still curable.
Persistent bloating and feeling full quickly
The ovarian one, and much harder to act on because the symptoms are so ordinary. What matters is persistence and change: bloating present on most days for three weeks or more, particularly new in a woman over fifty, alongside feeling full quickly or abdominal discomfort. That combination warrants assessment rather than a dietary experiment.
A change in bowel or bladder habit that persists
Relevant to both, and to bowel disease in its own right. New urinary frequency or a persistent change in bowel habit lasting weeks deserves an explanation. See urinary and bowel changes.
Abdominal swelling with weight loss
Losing weight while the abdomen becomes larger is a specific combination that should be assessed promptly rather than watched. It is uncommon and it warrants an appointment. See unexplained weight loss.
A family history of these cancers
Ovarian, endometrial, breast or bowel cancer in close relatives — particularly at young ages — is worth raising, because BRCA and Lynch syndrome both change what should be done. This is the one situation where surveillance and preventive options genuinely apply. See family history.
Want Your Reports Explained Properly?
Which diagnosis, which stage, and what it changes — set out in plain language. The opinion is free.
If You Have Been Told You Have Both
An uncommon situation, and one where the wording of the report matters a great deal.
- Two primaries is a different diagnosis from one that has spread. Synchronous endometrial and ovarian cancers — two independent tumours — generally carry a considerably more favourable outlook than an endometrial cancer that has metastasised to the ovary.
- The distinction is made on pathology, not imaging. Pathological features and molecular findings are used to determine whether the two tumours are independent. Ask specifically which your report concludes.
- It affects your stage. Spread to the ovary from an endometrial primary raises the stage. Two separate early primaries are staged separately, which usually means a less advanced picture overall. See FIGO staging.
- It is a prompt for genetic assessment. Synchronous tumours occur disproportionately in younger women and are associated with Lynch syndrome, so testing is indicated. See genetic counselling.
- It is a situation for specialist review. The distinction is genuinely difficult and it changes treatment substantially, so specialist gynaecological pathology review and a full tumour board discussion are worth insisting on. See second opinion.
Why the Distinction Needs a Specialist
Two cancers or one that has spread is a difficult call, and it changes both the stage and the treatment.
Slides reviewed, not just the summary line
Tumour board for every diagnosis
Lynch counselling built in
MMR / MSI testing as standard
45-minute consultations
Second opinions welcomed, not resented
Take The Next Step
One Disease Warns You Early
Endometrial cancer bleeds. That single difference explains most of the gap in outcomes.
Real Stories. Real Voices.
15,000+ patients chose CION. Hear from them directly.
These aren't paid endorsements or written reviews. These are video testimonials from real patients and families — recorded on their own phones, in their own words. Pick any one. Watch it. Then decide.
4.8★800+ Google reviews
50+video testimonials
15,000+patients treated
Read all 800+ reviews on Google
Start Your Story. Book Free Consultation.
Common questions
Endometrial vs Ovarian — Frequently Asked Questions
What is the main difference between endometrial and ovarian cancer?
Where they start, and — far more consequentially — when they are found. Endometrial cancer arises in the lining of the uterus and produces abnormal bleeding early, particularly after menopause, which sends women to a doctor while the disease is still confined to the uterus. Ovarian cancer arises in the ovary or fallopian tube and produces vague symptoms such as persistent bloating, feeling full quickly and abdominal discomfort, which are easily attributed to diet, irritable bowel or ageing. As a result most ovarian cancers are found at an advanced stage. That timing difference explains most of the difference in outcomes between the two.
Can a CA-125 test or a pelvic scan screen me for these cancers?
No, and this is worth being clear about because health packages frequently include both and describe them as a check for gynaecological cancer. Large trials of ovarian cancer screening using CA-125 and ultrasound have not demonstrated a reduction in deaths, and no test has been shown to work for screening endometrial cancer in women at ordinary risk. CA-125 does have an established role — in assessing an ovarian mass already identified, and in monitoring known ovarian cancer — but it is raised by many benign conditions and is often normal when cancer is present. Symptom awareness is what works.
If my ovaries were removed for endometrial cancer, can I still get ovarian cancer?
The risk is very substantially reduced, since the organs are gone. Both ovaries and both fallopian tubes are removed as standard in surgery for endometrial cancer, partly because they are a possible site of spread and partly because the ovaries produce the oestrogen that drove the tumour. A small residual risk of primary peritoneal cancer — a disease closely related to ovarian cancer arising from the lining of the abdomen — remains, which is why new persistent abdominal symptoms should still be reported. But the ovarian cancer risk itself is largely removed.
I have been told I have both endometrial and ovarian cancer. What does that mean?
The crucial question is whether these are two independent primary cancers occurring at the same time, or one cancer that has spread from the uterus to the ovary — and they are very different situations. Synchronous endometrial and ovarian tumours, meaning two genuinely independent primaries, occur disproportionately in younger women and generally carry a considerably more favourable outlook than metastatic spread would. The distinction is made on pathological and molecular grounds rather than on imaging. It is also a recognised prompt for Lynch syndrome testing. Ask specifically which your report concludes, and consider specialist pathology review.
Do the same genetic conditions cause both?
Partly. Lynch syndrome raises the risk of both endometrial and ovarian cancer, along with bowel and several other cancers, which is one reason mismatch repair testing on an endometrial tumour matters beyond that tumour — it has implications for your own future risk and for your relatives. BRCA1 and BRCA2 variants substantially raise ovarian and breast cancer risk but are not a major cause of endometrial cancer. If you have a family history of ovarian, breast, endometrial or bowel cancer, particularly at young ages, that is worth raising with a genetics service.
Medical disclaimer: This page provides general information comparing endometrial and ovarian cancer, reviewed by a CION oncologist. It is not a substitute for individual medical advice. Neither disease has an effective screening test for women at ordinary risk. Persistent bloating, abdominal discomfort or a change in bowel or bladder habit lasting more than three weeks, and any bleeding after menopause, should be assessed by a doctor.